We are live on
!
Find out more
CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
CYTH
Delisted
CYTH was delisted on the 25th of March, 2025.
15 hedge funds and large institutions have $1.71M invested in Cyclo Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
15% more funds holding
Funds holding: 13 → 15 (+2)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
24% less capital invested
Capital invested by funds: $2.23M → $1.71M (-$526K)
Holders
15
Holders Change
+2
Holders Change %
+15.38%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$468K |
| 2 |
Renaissance Technologies
New York
|
+$316K |
| 3 |
VF
Virtu Financial
New York
|
+$126K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$5.1K |
| 5 |
BlackRock
New York
|
+$4.06K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$153K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$26.1K |
| 3 |
Two Sigma Advisers
New York
|
-$11.3K |
| 4 |
State Street
Boston,
Massachusetts
|
-$7.36K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.73K |